Clinical trial
Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings: A Randomized Clinical Trial
NCT07620223 is registered in ClinicalTrials.gov with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings: A Randomized Clinical Trial
- Lead sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 24, 2026
- Completion date
- January 31, 2029
- Enrollment
- 378 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatobiliary surgery, prophylactic antibiotics